Recent studies have suggested reduced altered low-frequency oscillations (LFOs) and cerebral blood flow (CBF) in subjects with Alzheimer’s disease (AD). These measures may reflect reduced neural activity and altered waste clearance but are subject to confounding effects from patient motion. This study of a cohort of AD and controls investigates interaction of patient motion with LFO from BOLD and CBF from multi-delay arterial spin labeling. Results demonstrate significantly increased motion in subjects with AD and a correlation of motion estimates with BOLD LFO but not with CBF. These results suggest motion should be considered for studies in neurodegenerative subjects.
This abstract and the presentation materials are available to members only; a login is required.